相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Study of the anti-JCV antibody levels in a Spanish multiple sclerosis cohort
Maria I. Dominguez-Mozo et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2017)
Anti-JCV antibody serostatus and longitudinal evaluation in a Portuguese Multiple Sclerosis population
I. Correia et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2017)
Stability and predictive value of anti-JCV antibody index in multiple sclerosis: A 6-year longitudinal study
Harald Hegen et al.
PLOS ONE (2017)
Anti-JC virus seroprevalence in a Finnish MS cohort
M. Kolasa et al.
ACTA NEUROLOGICA SCANDINAVICA (2016)
High cumulative JC virus seroconversion rate during long-term use of natalizumab
A. Vennegoor et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
Anti-JC virus seroprevalence in a Spanish multiple sclerosis cohort JC virus seroprevalence in Spain
Yolanda Aladro et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
JC virus seroprevalence and seroconversion in multiple sclerosis cohort: A Middle-Eastern study
Raed Alroughani et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values
Nicholas Schwab et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Anti-JC virus antibody titres increase over time with natalizumab treatment
J. Raffel et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Anti-JC virus antibody titres increase over time with natalizumab treatment
J. Raffel et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Anti-JC Virus Antibody Levels in Serum or Plasma Further Define Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
Tatiana Plavina et al.
ANNALS OF NEUROLOGY (2014)
A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification
Peter Lee et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort
Tomas Olsson et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort
A. K. Trampe et al.
NEUROLOGY (2012)
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
Gary Bloomgren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: Baseline results of STRATIFY-1
Carmen Bozic et al.
ANNALS OF NEUROLOGY (2011)
Anti-JC Virus Antibodies: Implications for PML Risk Stratification
Leonid Gorelik et al.
ANNALS OF NEUROLOGY (2010)
Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis
Chen S. Tan et al.
LANCET NEUROLOGY (2010)
分享论文
